Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How Pharma Majors like Pfizer Inc. (PFE), Johnson & Johnson (JNJ) And Merck & Co. Inc. (MRK) Are Responding To Alzheimer?

CNBC’s Meg Tirrell reported on the popular “Squawk Box” program that patients suffering from Alzheimer disease in U.S and across the globe are assuming epidemic proportions with “5 million people currently have Alzheimer’s in the united states” alone and has been estimated to have been the “sixth leading cause of death” in the country. The talk show participants then went on to discuss how pharma majors from across the globe like Pfizer Inc. (NYSE:PFE), Johnson & Johnson (NYSE:JNJ) and Merck & Co., Inc. (NYSE:MRK) have responded to this medical crisis.

Pfizer Inc. (NYSE:PFE)

The discourse on “Squawk Box” pointed out that currently available drugs “treat the symptoms” of Alzheimer and also pointed out the challenges faced by the multinational drug companies in producing drugs which address the “underlying cause of the disease”.

The program also threw light on the fact that close to 35.6 million patients are suffering from the old age disease of “Alzheimer’s or dementia” worldwide and even more worrisome are the expert estimates that its occurrence in patients is “expected to triple by 2050.”

Tirrell and her program guests then went on to discuss in detail the challenges that Pfizer Inc. (NYSE:PFE), Johnson & Johnson (NYSE:JNJ) and their peers are facing in designing drugs which prevent the occurrence of  Alzheimer’s by explaining that, “ we actually don’t know what causes it. We don’t understand the biology well enough beneath this disease to be able to treat it well.”

The program then went on to express hope on a effective drug being discovered by the likes of Pfizer Inc. (NYSE:PFE), Johnson & Johnson (NYSE:JNJ) and Merck & Co., Inc. (NYSE:MRK) in the near future by pointing out to the strong drug candidate pipelines these drug majors are working on currently. The participants pointed out that, “There’s 67 medicines in development, up from 22 in 2004.”

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!